HeraMED Raises $2.39m via convertible note placement
- Medical tech company HeraMED (HMD) raises roughly $2.39 million through a convertible note placement
- The company considers itself a leader in the digital transformation of maternity care thanks to its proprietary in-home maternity care platform, HeraCARE
- The placement was strongly supported by institutional and sophisticated investors
- The proceeds will fast-track the commercial roll out of HMD’s HeraCARE maternity care platform and HeraBEAT device, which are undergoing paid pilots globally
- Shares have closed flat at 19 cents on October 18
